NOX4 and diabetes mellitus: It is interesting to note that whilst our study indicates that NOX4 may protect ECFC angiogenic signalling in diabetes, EC-specific NOX4 expression is reported to drive associated microvascular dysfunction [46], as further evidence of the established complexity and context-dependent nature of ROS signalling [50].